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Introduction 
 
Over the past decade or more, tobacco companies have introduced cigarettes with lower content 
of some toxins than regular and light cigarettes.  These new cigarettes, referred to as a class as 
Potential Reduced Exposure Products (PREPs), have typically been introduced into test markets, 
not nationwide, which means they are not yet widely known or recognized by name or 
description by most consumers.  However, the introduction of these products is of great concern 
to public health advocates, who do not believe that enough research, particularly long term 
research, has been done to know whether or not the PREPs, even if proven to have reduced 
toxins, actually present a reduced health risk.  The fear in the public health community is that 
smokers who might have been motivated to quit may reverse those quit plans if they perceive an 
alternative, safer smoking option exists with the PREPs.  Likewise, there is concern that former 
smokers could be tempted back to smoking and non-smokers could be tempted to initiate 
smoking if they too perceive that PREPs present lower health risks than other cigarettes.  Having 
faced a similar situation with the introduction of “light” cigarettes – i.e. new product, insufficient 
research about its health implications -- public health officials are feeling cautious about PREPs 
and have called for development of a science to evaluate PREPs, as well as ongoing surveillance. 
 
The Center for Survey Research (CSR) at UMass Boston, under contract to the National Cancer 
Institute, is charged with leading a collaborative effort to develop survey questions for 
monitoring population responses to PREPs.  The first step in that effort is to review and evaluate 
measures that have been developed to date, to recommend refinements or changes, and to 
propose new items to fill any gaps that may be revealed.  The evaluation of existing measures 
was based on standard practice in survey item development and, when possible, examination of 
data on responses to the survey questions. 
 
In order to obtain as complete a set of existing measures as possible, we reviewed published 
literature on consumer reactions to PREPs and solicited input about ongoing studies from 
members of the project advisory group1, members of the Harm Reduction Network, and other 
members of the tobacco research community.  Appendix A is a list of studies we have included 
in the summary of current data on the subject of PREPs surveillance.  Appendix B is the full 
listing of PREPs-related questions for each included study. 
 
In summarizing what survey questions have been asked and what data are available, we have 
identified eight domains: 
 
 Awareness 
 Perceptions of risk and/or harmfulness 
 Trial 
 Interest in trial 
 Current use 
 PREPs as quit aids 
 Smokeless (awareness, risk, trial/current use, quit aids) 
 Miscellaneous topics (government safety oversight, tobacco industry image, ad images 
and terminology, important qualities in switching to a new product, genetically modified 
tobacco) 
                                                 
1  Jack Fowler, Gary Giovino, Lynn Kozlowski, Stephen Marcus, Anne McNeill, Rich O’Connor, Mark 
Parascandola, Linda Pederson, Gordon Willis 
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In the first section (A) of this report, we review and describe the existing measures, organized by 
these domains.  In the second section (B), we consider how to proceed in developing measures 
for ongoing surveillance of PREPs, specifically making recommendations about important 
targets of surveillance for the short term and proposing strategies for further testing.   
 
PART A.  REVIEW AND DESCRIPTION OF EXISTING MEASURES 
 
I.  Awareness 
 
Most surveys that cover anything about PREPs include some measure of PREPs awareness. The 
structure of different awareness questions is summarized in Diagram 1, with the initial 
distinction between questions that ask about PREPs in the abstract versus those that ask about 
specific brands, with further breakdowns within these groups.   
 
 
Diagram 1.  The Structure of PREPs Awareness Questions 
 
 
 
Table 1 summarizes the questions that have been used to measure awareness of PREPs as an 
abstract concept and shows the percentage of respondents aware of PREPs using two approaches, 
where data are available. 
 
 
AWARENESS 
PREPs in the abstract 
(Table 1) 
Specific brands 
(Table 2) 
Described as 
less harmful 
Describe the 
mechanism 
Recognition Recall 
Read 
brand 
name 
Show 
ad 
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Table 1.  Measures of Awareness of Preps in General 
 
Source Item Wording Percent of smokers affirming awareness 
 Description of PREPs as “less harmful”  
UMASS Tobacco companies are developing new types of 
cigarettes and other tobacco products that are 
supposed to be less harmful.  Have you heard of such 
products? 
31% 
ITC WAVE 2 Tobacco companies are developing new types of 
cigarettes or cigarette-like products that are supposed 
to be less harmful than ordinary cigarettes.  Have you 
heard of such products? 
39% 
AHS Cigarette companies are making new types of 
cigarettes or cigarette-like products that they claim 
are supposed to be less harmful than ordinary 
cigarettes.  Have you heard of such products? 
40% 
CIPREP Have you seen or heard of any new types of cigarettes 
or cigarette-like products that tobacco companies are 
developing that they claim are safer or less harmful 
than ordinary cigarettes? 
19% 
HUND 2006 In the past few years, tobacco companies in the 
United States have introduced new cigarette brands 
that claim to produce lower levels of cancer-causing 
chemicals in the smoke when compared to 
conventional light cigarettes.  Please answer the 
following questions about these new products.  Have 
you heard of these products? 
NA 
 Description of Mechanism  
   
BAND Tobacco companies have recently introduced 
products that look like cigarettes, but which heat the 
tobacco, instead of burning it.  They claim that these 
products contain less tar and produce less 
environmental tobacco smoke.  They also say they 
that they give a lower concentration of cancer-
causing chemicals in the smoke.  Have you heard of 
these products? 
 
13% 
 
• Description of PREPs as less harmful:  If the question asks whether a respondent is aware of 
a new cigarette described rather generally as designed to be “less harmful”, respondents 
understand this question to include cigarettes that are not PREPs but products which may be 
interpreted as “less harmful” because they are marketed as “natural” or “additive free”.  This 
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is apparent when there is a followup question asking the respondent to name such a product, 
and they name brands such as American Spirit and Winston No Bull.  Questions with a broad 
“less harmful” description have reports of over one-third having heard of such “less harmful” 
cigarettes (31% of smokers on the UMASS study, 39% of smokers on ITC WAVE 2, and 
40% of smokers on AHS).  The exception to these consistent findings is the CIPREP study 
conducted in Canada; that study found only 19% awareness among smokers.  
 
• Description of the mechanism for harm reduction:  A second way to measure general 
awareness of PREPs is to start the question with a description of the mechanism by which the 
harm reduction is supposed to be achieved.  For example, see the wording in Table 1 for the 
BAND survey.  Data from the BAND survey suggest a much lower level of awareness, with 
about 13% of smokers saying Yes to this question. 
 
Table 2 summarizes questions designed to measure awareness of specific PREPs products.  Two 
general approaches are used: recognition of products and unaided recall of products.  
Recognition has been measured by either showing a product advertisement or reading brand 
names. 
 
• Present names of one or more specific PREPs:   Use of a recognition question, in which the 
brand name is provided and respondents have to say if they’ve heard of it, yields higher 
reports of knowledge of specific brands, though the rates are very likely over-reports because 
a number of PREPs brands share names with other products.  For example, Eclipse is also the 
name of a gum, Accord the name of a car, and Omni the name of a hotel.  When respondents 
say they recognize those names, we cannot be certain that they are thinking of the cigarette 
brand or if they simply recognize the name more generally and, therefore, report having 
heard of it.  Before showing advertisements of Advance and Eclipse, the CPPS asked 
participants whether they had ever heard of either of the two brands.  The CPPS found about 
11% awareness of at least one of the two products among current smokers.  The HUND 2006 
study asked recognition of four brands which resulted in much higher PREPs reports.  
Combined, 42% of smokers claimed recognition of at least one of these brands.  FMO 2008 
found 53% of smokers recognized at least one PREP name included in their list (see Table 
2).  We expect these rates are highly exaggerated, given other data about recognition of 
PREPs.   
 
• Show a product advertisement:  In the HAMILTON 2004 study, respondents were shown an 
ad for either Advance, Eclipse, or Omni along with ads for regular and light cigarettes 
(rotating the possible combinations).  Respondents were told to look at the ads for as long as 
they would if they came upon them for the first time in a magazine.  They were then asked, 
“Have you ever seen ads for these particular cigarette brands before?”  Among smokers, 
awareness measured this way was just below 8% for the PREP shown.  A study of the new 
Marlboro Ultra Smooth used a similar approach of showing an advertisement to respondents, 
but we do not know the final results for that study.  These studies were not designed to 
provide general estimates of awareness of PREPs, but rather to investigate other aspects of 
reactions to particular products. 
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Table 2.  Measures of Awareness of Specific Preps 
 
Source Item Wording 
Percent of smokers 
affirming awareness 
(unless otherwise noted) 
 Recognition – read names  
CPPS Next I would like to ask you some questions about 
two new brands of cigarettes on the market, called 
Eclipse and Advance, which will soon be available 
everywhere.  They contain far less of many of the 
chemical compounds or toxins found in cigarettes 
that are believed to contribute to the risk of cancer 
and other illnesses.  Have you heard of either of these 
brands? 
11% 
HINTS II Next are some questions about new types of tobacco 
products that have been recently introduced.  Have 
you ever heard of a tobacco product called…? 
{Eclipse, Quest, MUS, Ariva, Revel} 
NA 
HUND 2006 Have you heard of any of the following cigarette 
products …? 
Advance 20% 
Omni 13% 
Accord 11% 
Eclipse 24% 
FMO 2008 New types of tobacco products have been recently 
introduced.  Please indicate below whether you have 
ever tried or heard of the product.  (Not heard of 
product, Heard of product but never tried, Have tried 
product for EACHY   Eclipse, Quest, Marlboro 
UltraSmooth, Ariva, Revel, Accord, Advance, Omni, 
Exalt, Stonewall). 
53% of smokers had 
heard of at least one 
PREP 
 Recognition – show a product advertisement  
HAMILTON 
2004 
Have you ever seen ads for these particular cigarette 
brands before?   
8% 
MUS Have you ever seen advertisements for {Marlboro 
Reds, Lights, UltraLights, UltraSmooth} before? 
NA 
 Unaided Recall  
HUND 2006 Please tell me the names that you recall of any of 
these new products. 
No PREPs named. 
BAND Do you know the names of any of these products?  
[SPECIFY] 
4% Eclipse 
(of smokers who’d 
heard of PREPs; less 
than 1% of all 
smokers) 
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Source Item Wording 
Percent of smokers 
affirming awareness 
(unless otherwise noted) 
ITC WAVE 2 Can you name any of these new products? [Y/N] 
What are the names? 
8% Eclipse  
2% Omni   
(of the 27% of 
smokers who said they 
could name a 
PREP;3% of all 
smokers) 
AHS Can you name any of these new products? {Y/N] 
What are the names? 
1% Eclipse  
<1% Advance 
(of all smokers) 
UMASS Can you name any of these new products? [Y/N] 
Please tell me the names of one or two of these 
products. 
6% Eclipse 
(of smokers who had 
heard of and said they 
could name a PREP; 
less than 1% of all 
smokers) 
CIPREP Can you name any new cigarette products that you 
think are less harmful?  What are they? 
No PREPs named. 
 
• Unaided recall of brand names:  Generally, use of recall questions, which requires 
respondents to come up with brand names on their own, yields very low reports and many of 
the brands respondents name aren’t PREPs at all. 
 
o The HUND 2006 study asked unaided recall of brand names before asking for 
recognition, but none of the responses that were given turned out to be PREPs but were, 
instead, things like “natural” cigarettes (such as American Spirit) or nicotine replacement 
products (such as Nicorette and Nicoderm).  This finding was not included in the 
published study, but reported in a personal communication. 
o The BAND survey, which had introduced the concept by describing the mechanism of 
harm reduction, asked the 13% percent of smokers who said they’d heard of a PREP if 
they knew the names of any of these products.  Most (61%) said No, another 15% said 
they didn’t know, and 14% refused.  That’s nine out of ten respondents combined, 
leaving only a handful who could name one, with Eclipse getting the highest report at 
4%.   
o On the ITC WAVE 2 survey, smokers who were aware of PREPs were also asked if they 
could name a PREPs product.  While 27% said they could, the number reporting specific 
brands is low (8% Eclipse and 2% Omni), with many reports of non-PREPs, such as 
Winston (6%), Marlboro Blend #27 (2%), American Spirit (1%), Lights (1%), medicinal 
nicotine (2%), smoke-free (3%), and herbal (3%).  In addition, 26% named Quest, a 
nicotine step-down brand designed to assist quitting, but  not a PREP.   
o On the AHS, virtually none of the recognized PREPs was named by even 1% of smokers, 
except for Quest, which was named by about 3%.   
o The UMASS study reports that among those who had heard of PREPs, 25% of smokers 
said they could name a PREPs product.  However, only 6% of those who said they could 
name a PREP named Eclipse, a true PREP, on the first mention.   
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o In Canada, the CIPREP study asked smokers who were aware of PREPs cigarettes if they 
could name one, and 53% said Yes.  However, as with the other studies, no one named an 
actual PREP. 
 
Summary of Awareness Questions 
 
It is important to accurately track level of awareness of PREPs.  Reviewing the different 
questions that have been used to measure awareness of PREPs, we believe that at least a couple 
of them seriously overstate the level of awareness.  Specifically, using a general description of a 
PREP as “less harmful” yields too many reports of non-PREPs, as does the use of name 
recognition of some PREPs brands, especially those that share a name with another product.  
Providing the mechanism and advertising strategies, as BAND does, tends to reduce reported 
awareness, but the potential variation in mechanisms or advertising in future products could 
make this a cumbersome approach. 
 
 
II.   Perceptions of risk and/or harmfulness of PREPs 
 
It is important to keep in mind that respondents’ perceptions of risk would be highly related to 
the description of the product provided to them as well as the context of the question within the  
survey instrument.  In some cases respondents are simply shown an actual advertisement which 
may or may not make claims about riskiness, while in other cases they are told that the product 
has fewer toxins or that “tobacco companies claim they have fewer toxins.”  This will affect 
perceptions depending on the respondent’s attitude towards tobacco companies. 
 
• Continuous scales 
 
A popular choice for measuring risk is the use of a continuous numeric scale, often formatted as 
a ladder.  The scales have varied on a number of dimensions: a) endpoints (0-10 versus 1-10), 
b) verbal anchors (anchoring to “regular cigarettes” versus no such anchor), and c) parameter 
being assessed (perceived health risk, amount of tar (HAMILTON 2004), amount of toxins 
(CPPS), or “things that might cause cancer” (HAMILTON 2004).  Table 3 summarizes what has 
been done and what the results look like for smokers from the studies using a continuous scale 
approach. 
 
The first three rows are all health risk ladders, so can be compared.  The first is a 1-10 ladder 
with no anchor comparison to regular cigarettes (HAMILTON 2004).  Regular cigarettes, in fact, 
when rated on the same ladder, yield an 8-plus.  In the second row, 8-plus is just about what a 
light cigarette gets rated when using a 0-10 ladder that anchors regular cigarettes at a 10 (CPPS).  
On these two ladders, PREPs ratings are 5.4 and 6.0, relatively close to each other despite 
differences in the ladder.  Shiffman (2003) uses a very similar approach to CPPS -- a 0-10 health 
risk ladder anchored at 10 for regular cigarettes -- but the results are quite different.  The CPPS 
found that about 79% of smokers gave the PREPs a rating lower than 10 (regular cigarettes), 
compared to 91% for smokers in Shiffman’s study.  Further, the CPPS had almost no one say 
(1%) that PREPs were completely safe (rated a 0), compared to 24% in the Shiffman study.  
These differences are large and suggest either a lack of reliability in the ladder rating system or a 
difference in the effect of the stimulus that respondents were offered, that is what they were told 
about the PREPs. 
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The fourth and fifth rows of the table both use ladders rating “things that might cause cancer” or 
”cancer-causing chemical compounds/toxins.”  Wording is variable, but they appear to be aiming 
at the same thing.  As before, HAMILTON 2004 uses a 1-10 ladder with no anchor and the 
CPPS is a 0-10 ladder anchored at 10 for regular cigarettes.  The ratings for PREPs on these two 
ladders are 6.6 and 5.5, respectively.  Clearly both are well below 10, but again, the difference 
suggests that we need to be cautious in how exactly we interpret results from ladders ratings, as 
they have no inherent meaning.  Only HAMILTON 2004 used a ladder to ask about amount of 
tar (sixth row of table). 
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Table 3.  Summary of continuous ladders to measure PREPs risk perception 
 
Source Question PREPs Ratings 
Lights 
Ratings 
Regular 
Ratings 
Important 
Features 
 
1 
 
HAMILTON 
2004 
This card has three health risk ladders that go from 1 to 
10.  The bottom rung of the ladder means very low health 
risk, which implies that even if you smoked the cigarette 
regularly for a long time, like 20 or 30 years, you 
probably wouldn’t get a serious health problem.  The top 
rung of the ladder means very high health risk, which 
implies that if you smoked the cigarette regularly for a 
longtime you’d be very likely to get a serious health 
problem.  Please tell me where you would put each of the 
three cigarettes {Advance/Eclipse/Omni} on the health 
risk ladder.   
5.4 5.8 8.2 1-10 HEALTH 
RISK ladder; no 
anchor 
comparison to 
regular cigarettes. 
 
MUS used the 
same Q.  No data 
available. 
 
2 
 
CPPS 
Now think about the overall health risk ladder where 0 
means no health risk and a 10 means the health risk of 
smoking regular, full-flavor cigarettes.  Please tell me 
where you would put {Advance/Eclipse} on the health 
risk ladder? 
6.0 
79% believe it is 
lower than 
regular cigs 
(gave a rating 
<10); 1% said 
completely safe 
(rating=0) 
8.3  0-10 HEALTH 
RISK ladder; 
anchor 
comparison to 
regular cig. 
 
3 
 
SHIFFMAN 
2003 
We don’t have the wording of the risk question, but from 
the Shiffman article we know smokers were asked about 
the perceived risk of Eclipse, evaluated by rating its risk 
on a 0–10 scale, where 0 referred to ‘‘not smoking—all 
health risk eliminated’’ and 10 referred to the risk of 
smoking regular cigarettes. 
91% believe it is 
lower than 
regular cigs 
(gave rating 
<10); 24% said 
completely safe 
(rating=0) 
  0-10 HEALTH 
RISK ladder; 
anchor 
comparison to 
regular cig. 
 
4 
 
HAMILTON 
2004 
Looking at these ladders again, please consider these 
three ads {Advance/Eclipse/Omni} again—this time 
rating them from 1-10 with respect to the level of things 
that might cause cancer you think each product contains.  
A rating of 10 would mean you see this cigarette as 
having a high content of things that might cause cancer 
and a rating of 1 means you think the product has a low 
content of things that might cause cancer.  
6.6 6.9 8.8 1-10 AMOUNT 
OF THINGS 
THAT MIGHT 
CAUSE 
CANCER ladder; 
no anchor 
comparison to 
regular cigarettes. 
 
5 
 
CPPS 
Now think again about the earlier ladder for the amount of 
cancer-causing chemical compounds or toxins in 
cigarettes, where a rating of 0 means no chemicals or 
toxins that cause cancer and a 10 stands for the amount of 
chemicals or toxins in a regular, full flavor cigarettes like 
Marlboro or Salem or Camel.  Please tell me where you 
would put {Advance/Eclipse} to indicate its level of 
cancer-causing chemicals compounds or toxins.  
5.5 7.6  0-10 AMOUNT 
OF CANCER-
CAUSING 
CHEMICAL 
COMPOUNDS 
OR TOXINS 
ladder; anchor 
comparison to 
regular cig. 
 
6 
 
HAMILTON 
2004 
Looking at these ladders again, please consider these 
three ads {Advance/Eclipse/Omni} again—this time 
rating them from 1-10 with respect to the amount of tar 
you think each product contains.  A rating of 10 would 
mean you see the product as having a high tar content and 
a rating of 1 means you think this cigarette has a low tar 
content. 
5.3 5.4 8.4 1-10 AMOUNT 
OF TAR ladder; 
no anchor 
comparison to 
regular cigarettes. 
 
MUS used the 
same Q.  No data 
available. 
 
• Risk compared to lights or regular cigarettes in a yes/no format 
 
An alternative approach to measuring risk is a Yes/No question, comparing PREPs to light or 
regular cigarettes.  ITC WAVES 1 and 2 ask, “As far as you know, are any of these new products 
less harmful than ordinary cigarettes?”  In the WAVE 2 survey, of smokers aware of PREPS, 
24% said less harmful, 53% said not less harmful, and 23% were unsure.  The later WAVES (3 
and 4) modified this wording slightly as follows:  “Compared with ordinary cigarettes, are any of 
these new products less harmful?”  There was a followup question as well, depending on the 
respondent’s answer.  IF YES, “Are they a little or a lot less harmful than ordinary cigarettes?”  
IF NO, “Are they more harmful or the same as ordinary cigarettes?”  Data are not currently 
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available from the later waves.  The AHS asks a similar question, “Do you believe that any of 
these products are less harmful than ordinary cigarettes?” and 10% of smokers said they believed 
they were.  Similar approaches were used in the HINTS II (“As far as you know, is {brand} less 
harmful than conventional cigarettes, equally harmful, or more harmful than conventional 
cigarettes?”) and the MUSFG (“Compared to your regular cigarette/lights/ultralights, how much 
is risk reduced with MUS?”).  That survey followed up with the question, if a reduction in risk is 
expected, “What particular risks do you expect to change?”  Data are not yet available for 
HINTS II or MUSFG. 
 
• Less risk as a reason for interest in trying 
 
A more indirect approach to assessing risk perception is to include reduced risk as part of a list of 
reasons one is interested in using or trying the products.  For example, HINTS II asks, “What is 
the main reason you use/tried/used {brand}?” and offered “Instead of quitting, as a way to 
reduce health risks” as one of the answer options.   
 
• Other questions that assess perceptions of exposure and risk 
 
The CIPREP study done in Canada asked smokers who were aware of PREPS, “As far as you 
know, what is it about any of these products that might make them safer or less harmful?” They 
field coded open-ended responses as follows:  Less tar/lower tar (11%), Less nicotine (16%), 
Fewer chemicals/toxics/carcinogens (19%), Less harmful ingredients in general (9%), Less 
additives (9%), Self-extinguishing cigarettes (5%), Different filters/no fiberglass (4%), Other 
mentions (6%).  A quarter (25%) said they weren’t less harmful and another 15% said they did 
not know (multiple answers were possible). 
 
The CPPS tried a number of different questions to try to get at perceptions of toxin exposure as 
well as risk, attempting to directly address the messages that were explicit or implied in the ads 
that respondents were shown.  The survey asked the following questions: 
 
A.  If a smoker switched to {Advance/Eclipse} instead of continuing to smoke their regular 
cigarettes, do you think they would be exposed to fewer cancer causing chemicals?  61% of 
smokers said Yes. 
 
B.  Given your understanding of the materials about {Advance/Eclipse}, how many of the cancer 
causing chemicals found in regular cigarettes have been reduced in {Advance/Eclipse} – would 
you say…? All (16%), Most (26%), Some (46%), None (13%) (Smokers only) 
 
C.  If a smoker switched to {Advance/Eclipse} instead of continuing to smoke their regular 
cigarette, do you think that their chance of getting cancer would…? [increase, decrease, or not 
change]  FOLLOWUP:  Would you say it would {increase/decrease} a…? [large amount, 
moderate amount, small amount].  The combined results among smokers found 4% thought a 
switch would increase their chance of getting cancer a moderate amount, 57% expected no 
change, 10% thought their chance of getting cancer would decrease a small amount, 23% thought 
it would decrease a moderate amount, and 7% thought it would decrease a large amount. 
 
D.  Do you think if new smokers started out smoking {Advance/Eclipse}, they could smoke for 
more years before endangering their health?  Definitely yes (5%), probably yes (48%), probably 
not (27%), definitely not (21%)  (Smokers only) 
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In general, what sort of picture do the answers to these questions paint about smokers’ perception 
of exposure and risk for PREPs?  The results are not entirely consistent, which suggests that 
survey design can influence how much we believe the public is accepting the advertising 
messages.  For example, from question A above, 61% see a decrease in exposure to cancer-
causing chemicals, while from B, 88% see all, most, or some chemicals in PREPs reduced.  Both 
numbers are high, but the latter one suggests a truly impressive effect of the materials that were 
presented (advertising plus industry graphs about toxins).  The questions that follow these two on 
exposure can be used to understand whether or not that belief in reduced exposure translates into 
beliefs about smokers’ chances of actually getting cancer.  From question C, we find that about 
40% believe that smokers’ chances of getting cancer are decreased a small, moderate, or large 
amount.  But question D suggests that slightly more people believe that PREPs offer reduced 
risk, as 53% report that a new smoker could definitely or probably smoke PREPs longer before 
getting cancer. 
 
Summary of Risk Questions 
 
There are three main ways that risk has been assessed -- the continuous numeric scale (formatted 
as a ladder), yes/no questions that ask people to directly compare PREPs to lights or regular 
cigarettes, and a more indirect approach, letting respondents volunteer reduced risk as their 
reason for being interested in trying PREPs.  The ladders differ along a number of dimensions 
(scale, anchor, and parameter assessed) and seem susceptible to variability in answers, though it 
can be very useful to have a continuous variable outcome measure for modeling.  The yes/no 
format also seems like a good approach, in part because it is straightforward for respondents.  
The more indirect approach, letting respondents volunteer it as a reason for interest, also has 
merit in that it allows us to see how salient reduced risk is among other reasons for interest in the 
product.  It is also important to include questions about both reduced exposure and reduced risk, 
as these ideas are closely connected in consumers’ minds and may be critical in efforts to counter 
misperceptions in response to PREPs’ marketing. 
 
 
III. Trial 
 
There is somewhat less variation in the rather straightforward concept of having tried a PREP. 
Table 4 shows the detailed wording and data, where available, for the trial questions.  The 
questions vary along two dimensions: 
 
• reference period -- tried versus ever tried versus used in the past six months 
• product reference -- any of the products or one of the products or product name. 
 
The product reference used in a particular question was typically chosen to match either a 
preceding introductory sentence or two describing PREPs, or it followed other questions that 
referenced PREPs or PREPs brands. 
 
There is quite a lot of variation in reports of having tried PREPs, but they mostly have to do with 
who was asked the information -- specifically, some surveys screened out respondents who had 
never heard of PREPs while some asked all smokers. Table 4 recalculates rates, when necessary, 
to refer to all smokers. The rate from HUND 2006 (11% of smokers) looks high compared to 
reports from HAMILTON 2004 (1% of smokers), from HINTS (5% of smokers), or from AHS 
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(5% of smokers).  Even the 5% report from AHS may be too high, since some respondents were 
reporting about reduced harm cigarettes that are not really what we consider PREPs (e.g., 
“natural” cigarettes).  Not surprisingly, questions that ask about trial of specific brands by name 
yield lower rates in general than the broader questions about use of “these kinds of products.”  
The Tobacco Use Supplement to the Current Population Survey, which asked about trial of 
specific brands, found reports ranging from less than one percent (for six brands that were listed) 
to about 2% for Eclipse. 
 
Table 4.  Detailed questions and data about trial of PREPs 
 
Source Item wording Percent of Smokers (unless otherwise noted)
HUND 2006 Have you tried any of those products? 
(REFERRING TO 4 SPECIFIC BRANDS)  [Y/N]
11% 
BAND Have you ever tried one of these products? [Y/N] 2%  
HAMILTON 
2004 
 
Have you ever smoked any of the three cigarette 
brands? [Y/N] Which brands have you smoked?  
1% 
HINTS Tobacco companies have recently introduced new 
types of cigarettes that are claimed to have fewer 
harmful chemicals or carcinogens. These have 
names like Eclipse, Accord, Advance, and Omni. 
Have you ever tried one of these products? [Y/N] 
5% 
HINTSII You said that you have heard of {brand(s)}.  Have 
you ever tried this product/any of these products? 
Which ones? [Accord, Advance, Ariva, Eclipse, 
Exalt, MUS, Omni, Quest, Revel, Stonewall] 
No data available 
ITC WAVE 
1 
Have you ever tried any of these products? [Y/N]   
Which products have you ever tried?  Which 
products have you tried in the last 6 months?  
No data available 
ITC WAVE 
2, 
 
Have you tried any of these products in the last 6 
months? [Y/N]  
 
Less than 1% 
ITC WAVES  
3 AND 4 
 
Have you tried any of these products in the last 6 
months? [Y/N]  
 
No data available 
YSCS 24 
MONTH 
FOLLOWUP 
 
Have you ever tried [product = MUS; Ariva, Revel, 
or Exalt; Omni or Advance; Eclipse or Accord; 
Quest], even a puff? [Y/N] 
 
 
No data available 
CPPS Have you ever tried either of them? [Y/N]   Which 
have you tried? [Eclipse/Accord/Both]  
3% 
CPPS Have you used either of these new products in the 
past 6 months? [Y/N] Which have you used? 
[Eclipse/Accord/Both]. 
Less than 1%  
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Source Item wording Percent of Smokers (unless otherwise noted)
AHS Have you ever tried any of these products? [Y/N]   
Which one(s)? 
 
5% (The individual brand 
reports for PREPs were 
less than 1% combined.) 
AHS Altogether, how long did you use {product}? [days, 
weeks, months, years]  When was the last time you 
used {product}? 
Only 1% reported 
duration in excess of 30 
days, and no one reported 
use in the last 30 days. 
UMASS Have you ever tried any of these products? Which 
ones have you tried?  Have you used any of these 
products in the past month? 
4% (13% of those who 
had heard of PREPs. Less 
than 1% of smokers 
reported trial of an actual 
PREP)   
FMO 2008 New types of tobacco products have been recently 
introduced.  Please indicate below whether you 
have ever tried or heard of the product.  (Not heard 
of product, Heard of product but never tried, Have 
tried product for EACHY   Eclipse, Quest, Marlboro 
UltraSmooth, Ariva, Revel, Accord, Advance, 
Omni, Exalt, Stonewall). 
8% of smokers had tried 
at least one PREP 
TUS-CPS Now I'm going to ask about your use of new 
tobacco products that are sometimes claimed to 
have fewer harmful chemicals.  Have you ever tried 
a product called…. 
2%  Eclipse 
<1% Accord 
<1% Arriva 
<1% Exalt 
<1%  Revel 
<1% Omni 
<1% Advance 
(3% of daily smokers 
tried any PREP) 
 
Summary of Trial Questions 
 
The trial questions that have been used are all of a similar type, though they vary by reference 
period and by product reference, based on whether a survey is asking about specific named 
products or PREPs in general.  Questions that ask about PREPs in general likely suffer from the 
same overstatement as awareness questions because respondents include non-PREPs products, 
especially “natural” cigarettes and other “less harmful” tobacco products. 
 
 
IV.   Interest in trial 
 
The questions that have been asked about interest in trying PREPs, shown in Table 5, either ask 
directly about specific brand interest or they ask about interest in reduced exposure/harm 
products in general, with the latter being the more common.  Other important differences in the 
question wording include whether respondents were asked about trying, switching, or even 
purchasing a PREP, and whether there are any conditions placed on the trial, such as the price or 
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taste.  Not surprisingly, variation in answer options leads to big variation in response 
distributions. 
 
The questions that did not specify brand were asked of either all smokers or just those who were 
not aware of or had not tried a PREP.  For example, after an earlier item that described PREPs in 
general, the BAND study and the AHS asked the same question about interest in trial (see 
Table 5 for wording).  Of the smokers who were not aware of PREPs or had not tried them, 46% 
of those in BAND said that they would be interested.  In the AHS data for smokers who were not 
aware of or had not tried a PREP, interest was a bit higher at 52%. 
 
Table 5.  Detailed questions and data about interest in trying PREPs 
 
Source Item wording Percent of Smokers (unless otherwise noted) 
BAND Would you be interested in trying one of these 
products?   
46% of smokers not 
aware of PREPs or 
had not tried them  
AHS Would you be interested in trying one of these 
products? 
52% of smokers not 
aware of or had not 
tried a PREP 
HINTS If a new cigarette were advertised as less harmful than 
current cigarettes, how interested would you be in 
trying it?  Would you say very interested, somewhat 
interested, or not interested 
59% very/somewhat 
interested  
FMO 2008 If a new cigarette were advertised as less harmful than 
current cigarettes, how interested would you be in 
trying it?  (Not at all interested, Somewhat interested, 
Interested, Very interested, Extremely interested).   
77% of smokers 
reported being 
somewhat interested, 
very interested or 
extremely interested 
CIPREP How likely would you be to switch to a safer or less 
harmful cigarette product if it were available?  Would 
you be very, somewhat, not very or not at all likely? 
51% very likely 
27% somewhat likely 
CIPREP Would you be willing to pay a lot more, somewhat 
more, or no more than you are paying now, for a safer 
or less harmful cigarette product?   
24% a lot/somewhat 
72% no more 
CIPREP How likely would you be to switch to a safer or less 
harmful cigarette product instead of trying to quit 
smoking?  Would you be very, somewhat, not very or 
not at all likely?”   
32% very likely 
29% somewhat likely 
HUND 2006 Would you be interested in trying one of these 
products?  (four brands)   
50% Yes 
CPPS If they were priced right and tasted good, how likely is 
it that you would switch to Advance or Eclipse -- would 
you say very likely, somewhat likely, not very likely, 
not at all likely? 
60% very/somewhat 
likely 
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Source Item wording Percent of Smokers (unless otherwise noted) 
MUS If offered a {brand} cigarette, how likely would you be 
to try it?  (I definitely will; I probably will; I probably 
will not; I definitely will not).  How likely are you to 
purchase a pack of {brand} in the next year? 
NA 
SHIFFMAN 
2003 
Exact wording not available. Smokers were asked about 
interest in purchasing Eclipse in the next 6 months. 
57% very/somewhat 
likely 
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Summary of Interest in Trial Questions 
 
A number of variations in question wordings have been used.  The main variations are whether 
you ask about specific brands or interest in PREPs in general, whether you ask about trying or 
switching or purchasing, and whether there are any conditions placed on the trial, such as price 
or taste.  Even though switching seems like the highest hurdle -- a greater commitment than 
either trying or purchasing, and premised on good taste and fair price -- it yields high reports of 
interest.    
 
 
V.  Current use 
 
A number of surveys collected data about current use of PREPs, though they are split between 
asking about “now” and the past 30 days as the reference period.  HINTS II and ITC asked about 
current use as follows (though we do not have the data): 
 
• HINTS II -- “Do you now use {brand} every day, some days, not at all?”  
• ITC WAVES 3 and 4 -- “Are you still using any of these products? How often do you 
currently use {product named}?  Would that be daily, Less than daily but at least once a 
week, Less than weekly but at least once a month, Less than monthly, Or have you stopped 
using such products altogether?”   
 
The UMASS and YSCS 6-month and 12-month follow-ups asked about use in the past month or 
30 days.  The YSCS, after establishing if the respondent had used any “other” tobacco products 
in the past 30 days, asked, “What other tobacco products did you use?  Did you use… {Ariva, 
Revel, or Exalt; SCoR; OMNI or Advance; Eclipse or Accord; Quest}?”  The usage rates from 
this survey are extremely low, less than 1%.  The YSCS 24-month followup also asked about 
usage in the past 30 days for any of the PREPs (same list as for their other two surveys, except 
substituting MUS for SCoR) that the respondent had tried:  “Have you smoked {product} in the 
last 30 days?  During the last 30 days, on how many days did you smoke {product}?”  We do not 
have the data from the 24-month followup.  The UMASS study asked those who had tried a 
PREP (4% of smokers), “Have you used any of these products in the past month?”  They found 
24% report having used them in the past month – i.e. less than 1%. 
 
Summary of Current Use Questions 
 
Once a threshold of trial is reached, current use will become a key surveillance concept. 
Questions that have been used to measure current use ask either about now or about the past 30 
days.  Mirroring standard questions for current cigarette or smokeless use would probably be the 
best idea.  
 
 
VI.   PREPS as quit aids 
 
Questions about PREPs as quit aids come mainly in two forms:  direct questions about whether 
respondents think PREPs would be or have been used for quitting and indirect approaches that 
ask about reasons for interest, with quit aid as one of the reasons.  Two studies tried slightly 
different approaches to the topic of PREPs as quit aids -- one study asked a hypothetical question 
 17
about switching to PREPs instead of quitting and the other asked about advertising messages.  
The exact wordings for questions about PREPs as quit aids are shown in Table 6. 
 
Table 6.  Detailed questions and data about PREPs as quit aids 
 
Source Item wording Percent of Smokers (unless otherwise noted) 
AHS Did you use {product} instead of quitting cigarettes, 
as a way of cutting down on cigarettes, to help you 
quit smoking cigarettes? 
2% said instead of 
quitting or to help quit; 
3% said as a way of 
cutting down 
ITC WAVES 
2, 3,4 
Did you use these products as an alternative to 
quitting?   
In the past six months, did you use any of these 
products as a way of cutting down on your cigarette 
smoking?    
Did you use these products to help you quit?” 
(Emphasis added to highlight wording differences) 
NA 
CPPS Do you think switching to {Advance/Eclipse} 
would be a useful step for someone who wants to 
quit smoking? 
53% said Yes. 
HUGHES 
2005 
NA  51% believe that PREPs 
can help reduce the 
number of cigarettes 
smoked each day; 
53% believe that they can 
make it easier to quit 
smoking completely. 
CIPREP How likely would you be to switch to a safer or less 
harmful cigarette product instead of trying to quit 
smoking?  Would you be very, somewhat, not very 
or not at all likely? 
61% said very or 
somewhat likely to switch 
instead of quit. 
HAMILTON 
2004 
Now I’d like you to think about the three 
advertisements that you saw.  I want to know what 
message you think each ad is trying to give you.  
Look at the ad for {brand} while I read off some 
possible messages.  For each possible message, tell 
me whether you think this is what the ad is trying to 
say.  This cigarette will help someone quit smoking. 
About 41% said Yes. 
 
Summary of PREPs as Quit Aids Questions 
 
Quit aid questions have been asked as hypotheticals (would they be useful as quit aids) and 
actual (did you use them that way), as well as indirectly (with respondents naming quit aid as a 
reason for interest in PREPs). While we do not feel that this is a key surveillance topic at this 
time, if use increases, the best approach would probably be asking about actual use as quit aids.    
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VII.  Smokeless PREPs 
 
Awareness of traditional smokeless products (snuff and chewing tobacco) has been measured by 
surveys for many years.  Now that some smokeless PREPs are available, there is interest in 
measuring awareness and perceptions of them.  The issue is somewhat more complicated than 
surveillance of combustible PREPs due to two potential standards against which to assess 
harmfulness: cigarettes and traditional smokeless tobacco products. 
 
VIIA.  Smokeless Awareness 
 
ITC WAVE 2 and AHS, asked the following question:  “Are you aware of any smokeless 
tobacco products, such as snuff or chewing tobacco, which are not burned or smoked but instead 
are usually put in the mouth? [Y/N]”.  These surveys show similarly high rates (82% and 76%, 
respectively) of awareness of smokeless products among smokers.   
 
To date, only two surveys have attempted to measure awareness of non-combustible PREPs by 
naming them along with other types of PREPs and asking the respondent if he/she had heard of 
them.  For instance, HINTS II asks respondents, “Next are some questions about new types of 
tobacco products that have been recently introduced.  Have you ever heard of a tobacco product 
called…{Eclipse, Quest, Marlboro UltraSmooth, Ariva (S), Revel (S)}”.  Each product is asked 
about individually, and the products followed by an (S) indicate the smokeless products listed in 
the question.  Respondents are given another chance to mention a product not included in the 
above list:  “Have you heard of any other types of new tobacco products.  These would include 
products like Accord, Advance, Omni, Exalt (S), and Stonewall (S). [Y/N]”.  And if yes, “What 
other products have you heard of?”  The FMO 2008 mail survey also asks about awareness of 
smokeless products along with other PREPs:  “New types of tobacco products have been recently 
introduced.  Please indicate below whether you have ever tried or heard of the product. [Not 
heard of product, Heard of product but never tried, Have tried product for EACH…Eclipse, 
Quest, Marlboro UltraSmooth, Ariva (S), Revel (S), Accord, Advance, Omni, Exalt (S), 
Stonewall (S)]”.  Among the four smokeless products listed, rates of awareness among smokers 
who have heard of but have not tried the product ranged from 3% – 6%.  Therefore, awareness of 
these products appears to be comparable to combustible PREPs.  
  
VIIb.  Smokeless risk in relation to cigarettes 
 
The ITC WAVE 2 and AHS surveys followed up their question about traditional smokeless 
products with very similar questions asking respectively, “As far as you know, are any smokeless 
tobacco products less harmful than ordinary cigarettes?/Do you believe that any of the smokeless 
tobacco products are less harmful than ordinary cigarettes?”  A yes response for the ITC WAVE 
2 survey was almost 11% among smokers who were aware of smokeless products.  The AHS 
survey found 7% of respondents who thought smokeless products were safer than ordinary 
cigarettes.  It is important to remember that based on the awareness question the respondent just 
heard, these rates likely measure traditional smokeless products only.  HINTS II had a similar 
question which measures the new products:  “As far as you know, is {brand} [Less harmful than 
conventional cigarettes; equally harmful; more harmful than conventional cigarettes]?”  The 
brand filled in above would be the brand the respondent had been aware of when offered the 
recognition of brand names questions and those which the respondent said they had tried, but 
there are no data available for that survey at this time. 
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The AHS survey followed up with several more questions for smokers on smokeless products.  
They asked, “Do you believe that some smokeless tobacco products are less harmful than other 
smokeless tobacco products?”  Almost 12% of smokers said yes.  Next, respondents were asked, 
“Can you name the smokeless tobacco products that are the least harmful?” and only 
approximately 2% said that they could.  However, when pressed for the names of these products, 
none of the respondents were able to name a valid “less harmful” smokeless product.  Instead, 
respondents mentioned traditional smokeless products, like Copenhagen and Snuff.  Similarly, 
when smokers were asked if they had ever used the products they believed were less harmful 
(1.4% yes), again none mentioned a real PREP. 
 
VIIc.  Smokeless Trial/Current Use 
 
Several studies have asked smokers whether or not they have ever tried smokeless tobacco 
products.  The HINTS survey asked the following, “Tobacco companies have also recently 
introduced new types of smokeless tobacco products. These have names like Ariva, Exalt, and 
Revel. Have you ever tried one of these products?”  Less than 2% of smokers said yes to this 
question.  The FMO 2008 mail survey asks about awareness of smokeless products along with 
other PREPs.  “New types of tobacco products have been recently introduced.  Please indicate 
below whether you have ever tried or heard of the product. [Not heard of product, Heard of 
product but never tried, Have tried product for EACH…Eclipse, Quest, Marlboro UltraSmooth, 
Ariva (S), Revel (S), Accord, Advance, Omni, Exalt (S), Stonewall (S)]”.  Rates of ever use 
among smokers was 1% or less for each of the four smokeless products.  The YSCS  Baseline 
survey asked youth smokers if they used any other tobacco products in the past 30 days, and if 
so, whether or not they used Ariva, Revel or Exalt.  None of the youth smokers had used any of 
these products.  In sum, rates of use of smokeless products are extremely low among adult and 
youth smokers.  The YSCS 24-month follow-up and HINTS II also asked respondents if they 
ever tried smokeless products using brand recognition, as well as if they are currently using 
them, but there are not any data available for those two surveys at this time. 
 
VIId.  Smokeless Quit Aids  
 
The AHS survey asked respondents about using smokeless products as a quit aid as a follow-up 
to their question about awareness of traditional aids (“Are you aware of any smokeless tobacco 
products, such as snuff or chewing tobacco, which are not burned or smoked but instead are 
usually put in the mouth?”).  The survey asks, “Did you use any of these products... [instead of 
quitting cigarettes; as a way of cutting down on cigarettes; to help you quit smoking cigarettes]?”  
Fewer than one in ten (7%) of smokers said they used the products to cut down on cigarettes, 
almost 3% said they used them to help quit cigarettes and about 5% said they used the products 
instead of quitting cigarettes.  The HINTS II survey asked two questions which would measure 
whether or not smokers are using the newer products as quit aids, but there are not any data 
available for that survey at this time. 
 
Summary of Smokeless Questions 
 
In light of the new “snus” type products coming on the market and being promoted to smokers, it 
is of interest to measure awareness of them, to know how consumers perceive their relative 
harmfulness in comparison to cigarettes and other smokeless products, to measure trial and 
current use of them, and to understand their appeal as possible quit aids.  Only a few surveys 
have asked about the new products, and awareness and use are low, but that will likely change.  
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We recommend that surveillance of smokeless PREPs be measured as a separate concept from 
combustible PREPs. 
 
 
VIII.  Miscellaneous topics 
 
Government safety oversight 
 
A number of PREPs-related studies have broached the subject of government oversight of new 
tobacco products or their advertising.  Some of the questions are about what consumers think 
should be done, while others are about what consumers think is actually done.  As shown in 
Table 7, a summary of relevant question wording and data, where available, the HUND 2006 
study used both a knowledge question and an opinion question, both about the product itself.  
The BAND study also asked an opinion question, worded slightly differently from HUND 2006 
in that they named the US FDA for oversight, rather than “a governmental agency”, as worded in 
HUND 2006.  HAMILTON 2004 and CPPS asked knowledge questions about oversight of 
advertising claims, not the product: 
 
Table 7.  Detailed questions and data about government safety oversight 
 
Source Item wording Percent of Smokers  
HUND 2006 Do you think these products are evaluated for safety by 
the government before they can be sold to consumers? 
49% Yes 
BAND Do you think these products are evaluated for safety by 
the government before they can be sold to consumers? 
51% Yes 
HUND 2006 Do you believe that a governmental agency SHOULD 
be required to evaluate the safety of these products 
before they are sold to consumers? 
84% Yes 
BAND Do you believe that the U.S. Food and Drug 
Administration SHOULD be required to evaluate the 
safety of these products before they are sold to 
consumers? 
88% Yes 
HAMILTON
2004 
If an advertisement claims that a cigarette has less 
dangerous substances, do you think that a government 
agency has to approve the claim? 
67% Yes 
CPPS If a magazine advertisement, such as the ones I’ve 
shown you, claims that a cigarette has fewer toxins, do 
you think that a government agency approved the 
claim? 
47% Yes 
 
 
Tobacco industry image questions 
 
It would be reasonable to assume that consumer’s perceptions of the riskiness of PREPs is a 
function of the extent to which they trust cigarette manufactures and their advertising.  Likewise, 
to the extent that consumers believe that the tobacco companies are trying to reduce the 
harmfulness of their products, consumers may come to see them as more responsible and 
 21
trustworthy.  Hence, measuring perceptions of the industry could be an important component of 
monitoring reactions to PREPs.   
 
The CPPS asked a few questions about smokers’ perceptions of the tobacco industry: 
 
 “How honest do you think cigarette companies are about the safety of their products?”  
(Completely honest, Somewhat honest, Neither honest nor dishonest, Somewhat dishonest, 
Completely dishonest)  (20% of smokers said completely or somewhat honest, 16% said 
neither honest nor dishonest, 63% said completely or somewhat dishonest.) 
 “Compared to other product manufacturers, how honest do you think cigarette companies are 
about the safety of products - would you say they are more honest than other companies, less 
honest than other companies, or about as honest as other companies?”  (3% of smokers said 
more honest, 41% said less honest, and 56% said as honest as other companies.) 
 “Do you think that in the past few years tobacco companies have changed for the better, for 
the worse, or do you think that they have not changed?”  (36% of smokers said they have 
changed for the better, 8% said for the worse, and 56% said they have not changed.) 
 
Ad Images and Terminology -- “light”, “smooth”, “ultra”, etc. 
 
One of the issues that the public health community faces is how to prepare for the advertising 
and marketing of PREPs.  A number of surveys tried to understand how some advertising images 
were viewed and others attempted to gain insight to how certain words are understood by 
smokers.  The MUS study asked a number of questions about specific terms: 
 
“What does the word “light” mean to you?” 
“What does the word “smooth” mean to you?” 
“What does the term “ultra” mean to you?” 
 
In MUS focus groups, smokers were asked what the statements “UltraSmooth” and 
“FilterSelect” meant to them. 
 
MUS also asked advertising viewers to decide how well the advertised cigarette brand they saw 
fit a number of characteristics:  “I’d like you to give me your impression of {brand} on a variety 
of characteristics using a scale of -3 (completely unlikely) to +3 (completely likely).  Based on 
the advertisement you looked at, tell me how closely you believe {brand} fit each characteristic 
listed below:” 
 
Taste good Interesting Low tar Addictive 
Worth trying Fun Smell good Exciting 
Friends would like Make me nauseated Good with a drink Dangerous 
Stimulating Satisfying Mild Stupid 
Hard to quit Mature Cause cancer Sophisticated 
Harsh Strong Make me cough  
 
HAMILTON 2004 also asked about ad images:  “Now I’d like you to think about the three 
advertisements {Advance/Eclipse/Omni} that you saw.  I want to know what message you think 
each ad is trying to give you.  Look at the ad for {brand} while I read off some possible 
messages.  For each possible message, tell me whether you think this is what the ad is trying to 
say.   
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This cigarette tastes better than others. 
This cigarette is a good one to smoke when you’re with friends.” 
(This series also included “This cigarette is safer or healthier than others” and “This cigarette 
will help someone quit smoking”, but they are covered elsewhere in this summary.) 
 
Important qualities in switching to a new product 
 
In the PREPs studies we reviewed, we found one (CIPREP) that asked smokers to think about 
what product characteristics would be important in considering whether to switch to a PREP:  “If 
a safer or less harmful cigarette product were available, how important would each of the 
following qualities be for you in considering whether to switch to such a product? Using a scale 
from 1 to 7, where 1 is not at all important and 7 is extremely important, and the mid-point 4 is 
neither, how important would each of the following be? 
 
o the taste of the new product; 
o the ability to easily inhale the new product;  
o the extent to which the new product was less harmful to a smoker’s health;  
o the extent to which the new product was less harmful to the health of non-smokers 
from second-hand smoke;  
o the extent to which the new product was similar in price to cigarettes now on the 
market;  
o the extent to which the new product looks like an ordinary cigarette” 
 
Following is a summary of the smokers’ ratings on this item: 
 
Important Qualities in a Safer or Less 
Harmful Cigarette 
% Who Say Quality Is 
Extremely 
Important 
(score=7) 
Somewhat 
Important 
(score=5-6) 
Not  
Important 
(score=1-3) 
Extent of Harm to Non-Smokers’ Health 67 14 11 
Extent of Harm to Smoker’s Health 66 14 12 
Taste of Safer or Less Harmful Cigarette 39 28 18 
Price Similarity to Ordinary Cigarettes 38 18 26 
Ability to Easily Inhale 32 22 28 
Looks Like an Ordinary Cigarette 23 22 36 
 
Use of genetically modified tobacco 
 
The BAND survey asked a series of questions about genetically modified tobacco, covering 
awareness, perceived dangers, dissemination of information, and desire to avoid genetically 
modified tobacco: 
 
 “Does your cigarette brand contain any genetically modified tobacco?” (12% of smokers said 
Yes) 
 “Do you think that smoking genetically modified tobacco is more dangerous than smoking 
tobacco that has not been genetically modified?”  (32% of smokers said Yes)  
 “Do you think that tobacco companies should be required to inform consumers as to whether 
or not any of the tobacco used in their cigarette brand has been genetically modified?”  (81% 
of smokers said Yes) 
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 “Would you avoid using a cigarette brand if you found out it contained genetically modified 
tobacco?”  (46% of smokers said Yes) 
 
Summary of Miscellaneous Questions 
 
Of the various other topics that have been covered in PREPs surveys, government oversight and 
industry image questions are, perhaps, most interesting and useful.  Questions about government 
oversight have covered both the products themselves as well as the advertising, and they covered 
what people think is actually done as well as what they think should be done.  These types of 
measures could be useful for promoting policy change regarding FDA or FTC oversight.  The 
questions about industry image are useful because the belief that the industry is trying to make 
their products less harmful could improve their image and potentially reduce support for punitive 
actions against the industry. 
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PART B.  RECOMMENDATIONS FOR DEVELOPMENT OF SURVEILLANCE ITEMS 
 
We see the need for development of two different types of survey items with regard to consumer 
reactions to PREPs: 1) Population surveillance items – for ongoing tracking in order to detect 
important trends that could have public health ramifications; 2) Communications research items 
– to understand how the population may respond to variations in marketing of PREPs when and 
if they become widely available and reach a higher level of awareness in the population.  Of the 
concepts that we have reviewed to date, this is how we would allocate them to these two 
categories: 
 
Population Surveillance Communications Research 
• Awareness  
• Trial 
• Interest in trial among adult 
former smokers and youth 
• Perceptions of harmfulness 
• Government oversight 
• Tobacco industry image 
• Advertising images  
 
Because all indications are that population levels of awareness and trial of available PREPs is 
quite low (between less than 1% and 8 % of smokers), extensive population monitoring of 
patterns of current use and impact on changes in tobacco use behavior seems unnecessary at this 
time.  Once levels of PREPs awareness and trial increase, we would advocate introduction of 
current use measures in the surveillance program.  Likewise, we see the communications 
research, which would need to be done with regard to specific products, as a critical planning-
ahead strategy.  In order to be prepared to respond should these products become more widely 
available, it is important to learn how best to construct public health messages and policy to 
reduce negative health consequences.  This communications research will not be discussed 
further in this report.  The remainder of this section is about development of population 
surveillance items that are needed immediately. 
 
Development of Population Surveillance Items 
 
Awareness and Trial.  It is important to assess population awareness of PREPs as accurately as 
possible.  We suggest that awareness and trial of combustible and non-combustible PREPs be 
assessed separately.  We believe, at least for now, that the audiences for the products may be 
very different.  Historically, non-combustibles have been almost exclusively used by men of 
certain demographics.  Though there is clearly a new effort to expand the appeal for the new 
PREPs non-combustibles, for now it might be prudent to keep the non-combustible questions 
separate from the combustibles.  Further, the question wording is simplified if the concepts are 
kept separate.  The preceding summary of awareness questions demonstrates a number of 
different approaches that have been used, but none seems ideal.  
 
Interest in trial. Smokers’ interest in PREPs is important to the extent that using them would 
reduce their likelihood of quitting.  However, if smokers were asked whether they’d be interested 
in trying a cigarette that was less harmful than the one they are currently smoking, it is hard to 
imagine why someone would say no, if only not to look irrational.  On the other hand, if smokers 
are asked about their interest in an actual product or a potentially less harmful product, then 
interest in trying could be influenced by how much safer than their current cigarette they believe 
it to be, or how they think the taste would compare.  Consequently, we don’t feel that it is 
particularly useful to measure current smokers’ interest in trying a product that they are either 
aware of but haven’t yet tried or that they are not aware of.  However, we do feel that non-
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smokers’ interest in trying a hypothetical new tobacco product that was known to be less harmful 
would be a useful concept for surveillance because it would be an indication of the proportion of 
former smokers vulnerable to relapse and the proportion of non-smokers vulnerable to initiation.   
  
We recommend below two different strategies for assessment that seem worthy of further testing.  
For each one, we present some preliminary ideas about what questions to ask, a general 
description of the strategy, and the pros and cons of each approach. 
 
STRATEGY 1 
 
Possible questions to ask using strategy 1 
 
1.  Tobacco companies are developing new types of cigarettes or cigarette-like products that are 
supposed to be less harmful than ordinary cigarettes.  Have you heard of such products?  
(Yes/No) 
 
(IF YES) 
 
1a. Can you recall any brand names of these products? 
 
 1b. (IF YES) Please tell me the names of any you recall. 
 
1c. Have you used any of these products in the past 12 months?  (If so, which ones?) 
 
2. (Non-smokers only) If a new cigarette were developed that was scientifically proven to 
be less harmful than ordinary cigarettes, how likely would you be to try it?  (Very likely, 
somewhat likely, not very likely, not at all likely).  
 
3. Tobacco companies are developing new types of smokeless tobacco products that are 
supposed to be less harmful than ordinary smokeless tobacco, products that don’t involve 
spitting.  Have you heard of such products?  (Yes/No) 
 
(IF YES) 
 
3a. Can you recall any brand names of these products? 
 
 3b. (IF YES) Please tell me the names of any you recall. 
 
3c.  Have you used any of these products in the past 12 months?  (If so, which ones?) 
 
 General Description of strategy 1 
 
This strategy asks if respondent is aware of new tobacco products that are described as 
potentially less harmful, then follows up with a request for unaided recall of brand names.  To 
estimate awareness, one calculates the percentage of the open-ended responses that are actual 
known PREPs and multiplies that proportion by the percentage claiming awareness to the initial 
question.  For example, in the UMASS study, 31% of smokers said they had heard of new types 
of cigarettes and other tobacco products that are supposed to be less harmful.  Of those, only one 
quarter said they could name one.  Of those that offered names, only 6% actually named a PREP 
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(Eclipse) and another 3% mentioned a “smokeless” product.  Giving the benefit of the doubt to 
the mentions of “smokeless”, the highest possible percentage of smokers who said they could 
name a product who were actually aware of a PREP was 9%.  This method would reason that 
among the other 75% of smokers who said they were aware of PREPs but could not name one, 
9% were actually aware of a PREP and the others were probably thinking of “natural” or other 
types of conventional products.   Extrapolating to all smokers, we’d estimate that a total of 3% 
(9% of 31%) who have heard of such products, were aware of a PREP.  
 
Pros and Cons of strategy 1 
 
Pros  This measures awareness of the concept of PREPs and potentially removes the 
inflation factor due to confusion of PREPs with other products. 
 
 It allows for surveillance of perceptions of reduced harm in other tobacco 
products not recognized as PREPs. 
 
 If any PREPs start to be widely advertised and marketed, the percent recalling the 
brand can be expected to rise. 
 
Cons Coding of open-ended responses is labor-intensive. 
 
 The estimation process requires a more complex operational definition of 
awareness. 
 
 This strategy does not yield an “aware/unaware” code at the individual level, and 
consequently any internal analyses of demographics of awareness would be not be 
possible. 
 
STRATEGY 2  
 
Possible questions to ask using strategy 2 
 
1 I’m going to read you the names of some relatively new cigarette brands.  For each one, 
please tell me whether or not you have ever heard of it. 
 
 YES NO
Eclipse   
Accord   
Advance   
Marlboro Ultrasmooth   
Quest   
(Add in some phony names 
and regular cig names) 
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(IF YES TO ANY) 
 
2. You say you have heard of (name(s)). Do you believe that (any of those products 
are/that product is) less harmful than the usual brands of light cigarettes or do you 
believe that they are not less harmful than the usual brands?  (At least one is less 
harmful/None are less harmful) 
 
  (IF MORE THAN ONE MENTIONED AS “LESS HARMFUL”) 
 
3. Which do you believe are less harmful?  (Read names of recognized 
brands and get yes/no on less harmful for each one?) 
 
4. In the past 12 months, have you smoked any of those brands?  (If so, which 
one(s)?) 
 
5. (Non-smokers only) If a new cigarette were developed that was scientifically proven to 
be less harmful than ordinary cigarettes, how likely would you be to try it?  (Very likely, 
somewhat likely, not very likely, not at all likely).  
 
6. I’m going to read you the names of some relatively new tobacco products that are not 
smoked.  They are either sucked or held in the mouth.  For each one, please tell me 
whether or not you have ever heard of it. 
 
 YES NO
Ariva   
Revel   
Exalt   
Stonewall   
Camel Snus   
Taboka   
Skoal Dry   
(Add in some phony names)   
 
 (IF YES TO ANY) 
 
7. You say you have heard of (names). Do you believe that (any of those products 
are/that product is) less harmful than the usual smokeless tobacco or do you 
believe that they are not less harmful than the older products?  (At least one is less 
harmful/None are less harmful) 
 
  (IF MORE THAN ONE MENTIONED AS “LESS HARMFUL”) 
 
8. Which do you believe are less harmful than the usual chewing tobacco, 
dip or snuff?  (Read names of recognized brands and get yes/no on less 
harmful for each one?) 
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9. Do you believe that any of (READ NAMES OF PRODUCT(S) THEY’VE 
HEARD OF] is/are less harmful than cigarettes or do you believe that they are 
about as harmful as cigarettes?  (At least one is less harmful/None are less 
harmful) 
 
  (IF MORE THAN ONE MENTIONED AS “LESS HARMFUL”) 
 
10. Which do you believe (is/are) less harmful than cigarettes?  (Read names 
of recognized brands and get yes/no on less harmful for each one?) 
 
11. In the past 12 months, have you used any of those products?  (If so, which 
one(s)?) 
 
General Description of strategy 2 
 
This strategy asks for recognition of brand names with the brands being introduced as “new 
products” NOT “potentially less harmful products”.  Then, for those who indicate awareness of 
any, follow up to see if they think any of them are less harmful than a standard brand. 
 
Pros and Cons of strategy 2 
 
Pros This assesses familiarity with existing PREPs brands, and if one starts to be 
marketed intensively and become more generally available, the rate of its 
recognition should increase. 
 
 Although recognition rates are likely to be inflated for brands that are similar to 
other products (e.g. Accord, Eclipse), if none are seen to be less harmful in the 
follow-up question, the identification of the brand as a PREP could be discounted. 
 
 It avoids inflation of the awareness rate that occurs when unnamed “new, less 
harmful” products are the descriptor. 
  
 
Cons This strategy might underestimate awareness in two ways: 
 
 A) If a respondent is aware that a brand has been advertised as less harmful, but 
doesn’t believe the advertising, they would be coded as being unaware of any 
PREPs.  This would not be a problem if the agreed upon operational definition of 
awareness was knowledge of a specific PREP that a respondent perceives as 
less harmful. 
 
B)  If a respondent is aware that PREPs have been developed, but has not paid 
attention to particular brand advertising or promotion, they would be coded as 
being unaware of any PREPs. 
   
 
 
